FABP5L7 Inhibitors represent a specific class of chemical compounds designed to selectively hinder the activity of the FABP5L7 protein. FABP5L7, or Fatty Acid Binding Protein 5-Like 7, belongs to the fatty acid-binding protein family, a group of proteins known for their involvement in cellular lipid metabolism and transport. These proteins play crucial roles in facilitating the intracellular trafficking of fatty acids, contributing to processes such as energy storage, membrane synthesis, and signal transduction. The development of inhibitors targeting FABP5L7 is essential for scientific exploration, offering researchers specialized tools to unravel the molecular functions and regulatory roles associated with this specific variant of the fatty acid-binding protein family.
The synthesis and optimization of FABP5L7 inhibitors require a detailed understanding of the protein's structural characteristics and its interactions within cellular pathways. These inhibitors are meticulously designed for specificity, aiming to selectively bind to key regions of FABP5L7 and interfere with its normal lipid-binding activities. By employing FABP5L7 inhibitors in experimental settings, researchers can explore the consequences of protein inhibition on cellular lipid metabolism, shedding light on the specific substrates and molecular pathways influenced by FABP5L7. The study of FABP5L7 inhibitors contributes to the broader exploration of fatty acid metabolism, providing insights into the intricate molecular machinery that underlies cellular processes related to lipid transport and utilization.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, inhibiting transcription and preventing the synthesis of FABP5L7 mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide disrupts protein synthesis, leading to a reduction in FABP5L7 expression by inhibiting translation. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin induces premature termination of protein synthesis, impacting translation and lowering FABP5L7 levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, indirectly suppressing FABP5L7 expression by interfering with transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin hinders protein synthesis by blocking peptidyl transferase activity, leading to reduced FABP5L7 synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin interferes with mRNA synthesis, impacting transcription and contributing to the downregulation of FABP5L7. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting FABP5L7 expression by disrupting purine synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing FABP5L7 levels. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine intercalates into DNA, disrupting DNA structure and inhibiting transcription, leading to decreased FABP5L7 mRNA. | ||||||